International Journal of Pharmaceutics: X

OCT 6, 2026 · JOURNAL ARTICLE

A n-heneicosane solid emulsion as a single-dose subunit vaccine elicits broad and durable immune responses in an aged and a Pox virus model.

International Journal of Pharmaceutics: X

The development of single-dose vaccines capable of inducing durable humoral and cellular immune responses would eliminate the need for additional booster doses, which is particular

AUG 28, 2026 · JOURNAL ARTICLE

Nanoimmunomodulation for cartilage repair in osteoarthritis: reprogramming the inflammatory joint microenvironment.

International Journal of Pharmaceutics: X

Osteoarthritis is a whole-joint disease characterized by persistent inflammation, immune dysregulation, oxidative stress, cellular senescence, and impaired cartilage repair. Curren

AUG 26, 2026 · JOURNAL ARTICLE

Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.

International Journal of Pharmaceutics: X

A comprehensive review synthesizing current knowledge on biomaterial-based drug delivery for head and neck cancer, identifying clinical challenges and therapeutic opportunities without presenting original experimental data or clinical trial results.

AUG 19, 2026 · JOURNAL ARTICLE

Targeted Nanoparticle Delivery CRISPR/Cas9: overcoming biological barriers, enhancing stability, and improving therapeutic precision.

International Journal of Pharmaceutics: X

This is a narrative review proposing conceptual frameworks for nanoparticle-mediated CRISPR delivery; it does not report primary experimental data, efficacy outcomes, or comparative evidence.

AUG 16, 2026 · JOURNAL ARTICLE

Delivering the blueprint: Advances and challenges in mRNA therapeutics for the respiratory system.

International Journal of Pharmaceutics: X

This is a systematic review article synthesizing mechanisms, delivery methods, challenges, and safety considerations for mRNA-LNP therapeutics in pulmonary disorders, providing expert assessment of the field rather than reporting original trial data.

JUL 13, 2026 · JOURNAL ARTICLE

Exosome-like nanoparticles derived from Astragali Radix-Curcumae Rhizoma co-decoction enhance oral bioavailability and provide synergistic efficacy and reduced toxicity in combination with 5-fluorouracil for lung cancer therapy.

International Journal of Pharmaceutics: X

Preclinical mouse model data showing enhanced bioavailability and synergistic efficacy; no human safety or efficacy data yet available.

JUL 11, 2026 · JOURNAL ARTICLE

Artesunate-loaded bovine serum albumin nanoplatform with metal-polyphenol network coating for ferroptosis-driven breast cancer therapy.

International Journal of Pharmaceutics: X

Preclinical proof-of-concept in cell and animal models showing a novel nanoparticle formulation induces ferroptosis and tumor inhibition, but lacks human efficacy data, safety characterization, and direct comparator controls.

JUL 11, 2026 · JOURNAL ARTICLE

Emerging copper-based hollow nanoplatforms for cancer treatment.

International Journal of Pharmaceutics: X

This is a narrative review synthesizing preclinical and emerging evidence on copper-based nanoplatforms; no original experimental data, clinical trials, or comparative efficacy data are presented.